European equities traded in the US as American depositary receipts were slightly lower late Thursday morning, declining 0.12% to 1,510.10 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which rose 2.6% and 1.8%, respectively. They were followed by accommodations booking company trivago (TRVG) and financial services company Banco Santander (SAN), which were up 0.6% each.
The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which fell 9.2% and 3.9%, respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which were down 2.6% and 2.4%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB), which soared 203%, followed by fellow biotech firm Autolus Therapeutics (AUTL), which advanced 4.1%. Biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) Amarin (AMRN) increased 2% and 0.7%, respectively.
And the decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which dropped 11% and 6.4%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 3.8% and 2.4%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。